Questionnaire for data collection
Person in charge of human xenotransplantation practice.
Title : MD
First Name: I.S
Last name : Turchin
Address :
Zip :
State : Kiev
Country : Ukraine
Institution :
Telephone :
Email :
What is the source of your information about human xenotransplantation practices?
Congress
What is the therapeutic purpose of this xenotransplantation treatment?
Diabetes
Where and when is this human xenotransplantation practice taking place?
Country Ukraine
Timing 1995
Is this treatment part of a clinical trial?
Yes
How many patients are included in this clinical trial?
unknown
What are the inclusion criteria for patient selection?
i. Duration on the waiting list? unknown
ii. Life-threatening diseases without alternative therapy? No
iii. Is a protocol available? Yes
If yes, could you please send a copy?
What is the animal source of the xenotransplantation product?
Pig
Source animals Do you have information about source animals? No
Testing of safety : Do you have information about testing of safety? No
What type of cells/tissues/organs was transplanted?
Cells: Islets of Langerhans
Tissues:
Organs:
Others:
What type of exposure to xenogeneic cells was involved?
Solid-organ xenotransplantation: No
Cellular xenotransplantation: Yes
Tissue xenotransplantation: No
Human cells exposed to xenogeneic Feeder cell: No
Extracorporeal perfusion: No
Encapsulation: No
Other bioartificial isolation device:
Others:
Transplant Do you have information about transplant recipients? No
Have results been presented at a scientific congress?
Yes
if yes, where?
Turchin IS, Tronko MD, Komissarenko VP. Experience of 1.5 thousand transplantation of Beta-cells cultures to patients with diabetes mellitus. 5th IPITA congress, Miami.
Have results been published in a scientific journal?
No
if yes, where?
Is this human clinical trial performed with governmental and/or institutional oversight and supervision?
Unknown
if yes, which?
Comment